ICU Medical
Market Cap
US$4.2b
Last Updated
2020/09/19 05:38 UTC
Data Sources
Company Financials +
Executive Summary
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. More Details
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet with proven track record.
Similar Companies
Share Price & News
How has ICU Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ICUI has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
3.4%
ICUI
1.1%
US Medical Equipment
1.0%
US Market
1 Year Return
24.2%
ICUI
15.4%
US Medical Equipment
13.6%
US Market
Return vs Industry: ICUI exceeded the US Medical Equipment industry which returned 15.4% over the past year.
Return vs Market: ICUI exceeded the US Market which returned 13.6% over the past year.
Shareholder returns
| ICUI | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.4% | 1.1% | 1.0% |
| 30 Day | 9.3% | 1.5% | -0.4% |
| 90 Day | 11.1% | 12.0% | 8.9% |
| 1 Year | 24.2%24.2% | 16.4%15.4% | 16.2%13.6% |
| 3 Year | 7.4%7.4% | 73.3%68.8% | 40.2%30.8% |
| 5 Year | 79.8%79.8% | 149.6%130.6% | 89.6%68.2% |
Price Volatility Vs. Market
How volatile is ICU Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 hours ago | Simply Wall St
What Do The Returns On Capital At ICU Medical (NASDAQ:ICUI) Tell Us?1 week ago | Simply Wall St
ICU Medical (NASDAQ:ICUI) Is Growing Earnings But Are They A Good Guide?3 weeks ago | Simply Wall St
Is ICU Medical, Inc. (NASDAQ:ICUI) Worth US$198 Based On Its Intrinsic Value?Valuation
Is ICU Medical undervalued compared to its fair value and its price relative to the market?
49.68x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ICUI ($198.52) is trading above our estimate of fair value ($150.98)
Significantly Below Fair Value: ICUI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ICUI is poor value based on its PE Ratio (49.7x) compared to the US Medical Equipment industry average (49.4x).
PE vs Market: ICUI is poor value based on its PE Ratio (49.7x) compared to the US market (18.4x).
Price to Earnings Growth Ratio
PEG Ratio: ICUI is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: ICUI is good value based on its PB Ratio (2.9x) compared to the US Medical Equipment industry average (3.9x).
Next Steps
Future Growth
How is ICU Medical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
26.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ICUI's forecast earnings growth (26.5% per year) is above the savings rate (2.2%).
Earnings vs Market: ICUI's earnings (26.5% per year) are forecast to grow faster than the US market (23.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ICUI's revenue (2.6% per year) is forecast to grow slower than the US market (9.7% per year).
High Growth Revenue: ICUI's revenue (2.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ICUI's Return on Equity is forecast to be low in 3 years time (9.3%).
Next Steps
Past Performance
How has ICU Medical performed over the past 5 years?
10.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ICUI has a large one-off loss of $58.7M impacting its June 30 2020 financial results.
Growing Profit Margin: ICUI's current net profit margins (6.6%) are higher than last year (3.6%).
Past Earnings Growth Analysis
Earnings Trend: ICUI's earnings have grown by 10.4% per year over the past 5 years.
Accelerating Growth: ICUI's earnings growth over the past year (76.6%) exceeds its 5-year average (10.4% per year).
Earnings vs Industry: ICUI earnings growth over the past year (76.6%) exceeded the Medical Equipment industry -0.2%.
Return on Equity
High ROE: ICUI's Return on Equity (5.9%) is considered low.
Next Steps
Financial Health
How is ICU Medical's financial position?
Financial Position Analysis
Short Term Liabilities: ICUI's short term assets ($1.0B) exceed its short term liabilities ($359.2M).
Long Term Liabilities: ICUI's short term assets ($1.0B) exceed its long term liabilities ($88.1M).
Debt to Equity History and Analysis
Debt Level: ICUI's debt to equity ratio (10.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if ICUI's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: ICUI's debt is well covered by operating cash flow (112.3%).
Interest Coverage: ICUI earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is ICU Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ICUI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ICUI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ICUI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ICUI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ICUI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.7yrs
Average management tenure
CEO
Vivek Jain (48 yo)
6.58yrs
Tenure
US$2,825,277
Compensation
Mr. Vivek Jain serves as an Independent Director at Envista Holdings Corporation since April 7, 2020. He has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr. Jain ...
CEO Compensation Analysis
Compensation vs Market: Vivek's total compensation ($USD2.83M) is below average for companies of similar size in the US market ($USD5.70M).
Compensation vs Earnings: Vivek's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 6.58yrs | US$2.83m | 0.32% $ 13.1m | |
| Chief Operating Officer | 2.67yrs | US$2.50m | 0.037% $ 1.6m | |
| Corporate VP | 2.67yrs | US$1.40m | 0.0072% $ 297.2k | |
| Corporate VP & GM of Infusion Systems | 3.58yrs | US$1.40m | 0.029% $ 1.2m | |
| CFO & Treasurer | 0.50yr | no data | 0.0044% $ 182.1k | |
| Chief Accounting Officer | no data | no data | 0.011% $ 462.6k | |
| Executive Officer of Special Project Opertions | no data | US$1.05m | no data |
2.7yrs
Average Tenure
47yo
Average Age
Experienced Management: ICUI's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 6.58yrs | US$2.83m | 0.32% $ 13.1m | |
| Independent Director | 4.67yrs | US$267.01k | 0.0071% $ 294.3k | |
| Director | 36.67yrs | US$368.40k | 5.86% $ 243.6m | |
| Independent Director | 22.67yrs | US$257.51k | 0.11% $ 4.4m | |
| Independent Director | 2.67yrs | US$240.01k | 0.0033% $ 137.6k | |
| Lead Independent Director | no data | US$278.51k | 0.015% $ 635.9k | |
| Independent Director | 2.67yrs | US$240.01k | 0.0033% $ 137.6k |
5.6yrs
Average Tenure
59yo
Average Age
Experienced Board: ICUI's board of directors are considered experienced (5.6 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ICUI insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
ICU Medical, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: ICU Medical, Inc.
- Ticker: ICUI
- Exchange: NasdaqGS
- Founded: 1984
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$4.156b
- Shares outstanding: 20.94m
- Website: https://www.icumed.com
Number of Employees
Location
- ICU Medical, Inc.
- 951 Calle Amanecer
- San Clemente
- California
- 92673
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ICUI | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Mar 1992 |
| IC7 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Mar 1992 |
Biography
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company’s infusion therapy produc ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/09/19 05:38 |
| End of Day Share Price | 2020/09/18 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.